Pular para conteúdo

Doença de células falciformes (pediatria)

Gerenciamento da Crise de Oclusão Vascular e Síndrome Torácica Aguda

Manejo da dor

What is the best pharmacologic treatment for sickle cell disease pain crises? (abre nova janela)

Baker M, Hafner JW.

Fonte‎: Ann Emerg Med 2012;59(6):515-6.

Indexado‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (abre nova janela)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (abre nova janela)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Fonte‎: Thromb Haemost 2007;98(2):392-6.

Indexado‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (abre nova janela)

Terapia de hidratação (manejo de fluidos)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (abre nova janela)

Okomo U, Meremikwu MM.

Fonte‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indexado‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (abre nova janela)

Suplementação de Oxigênio

Guidelines for the management of the acute painful crisis in sickle cell disease. (abre nova janela)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Fonte‎: Br J Haematol 2003;120(5):744-52.

Indexado‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (abre nova janela)

Terapia respiratória e antibiótica

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (abre nova janela)

Ahmad FA, Macias CG, Allen JY.

Fonte‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Indexado‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (abre nova janela)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (abre nova janela)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Fonte‎: Hemoglobin 2004;28(2):85-102.

Indexado‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (abre nova janela)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (abre nova janela)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Fonte‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Indexado‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (abre nova janela)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (abre nova janela)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Fonte‎: Haematologica 2013;98(9):1375-82.

Indexado‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (abre nova janela)

Predictors of bacteremia in febrile children with sickle cell disease. (abre nova janela)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Fonte‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Indexado‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (abre nova janela)